RU2008103608A - Выявление антигена-мишени вне зависимости от присутствия или отсутствия соответствующего терапевтического антитела - Google Patents
Выявление антигена-мишени вне зависимости от присутствия или отсутствия соответствующего терапевтического антитела Download PDFInfo
- Publication number
- RU2008103608A RU2008103608A RU2008103608/15A RU2008103608A RU2008103608A RU 2008103608 A RU2008103608 A RU 2008103608A RU 2008103608/15 A RU2008103608/15 A RU 2008103608/15A RU 2008103608 A RU2008103608 A RU 2008103608A RU 2008103608 A RU2008103608 A RU 2008103608A
- Authority
- RU
- Russia
- Prior art keywords
- therapeutic antibody
- target antigen
- sample
- antibody
- complex
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title claims abstract 26
- 239000000427 antigen Substances 0.000 title claims abstract 17
- 102000036639 antigens Human genes 0.000 title claims abstract 17
- 108091007433 antigens Proteins 0.000 title claims abstract 17
- 238000000034 method Methods 0.000 claims abstract 21
- 238000003018 immunoassay Methods 0.000 claims abstract 6
- 230000015572 biosynthetic process Effects 0.000 claims abstract 5
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims abstract 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims abstract 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims abstract 2
- 102000010789 Interleukin-2 Receptors Human genes 0.000 claims abstract 2
- 108010038453 Interleukin-2 Receptors Proteins 0.000 claims abstract 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims abstract 2
- 229940120638 avastin Drugs 0.000 claims abstract 2
- 229940022353 herceptin Drugs 0.000 claims abstract 2
- 229960004641 rituximab Drugs 0.000 claims abstract 2
- 238000012544 monitoring process Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05014618.2 | 2005-07-06 | ||
| EP05014618 | 2005-07-06 | ||
| EP06004447 | 2006-03-06 | ||
| EP06004447.6 | 2006-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2008103608A true RU2008103608A (ru) | 2009-08-20 |
Family
ID=36922121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2008103608/15A RU2008103608A (ru) | 2005-07-06 | 2006-07-05 | Выявление антигена-мишени вне зависимости от присутствия или отсутствия соответствующего терапевтического антитела |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070009976A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2194380A3 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008545145A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20080016939A (cg-RX-API-DMAC7.html) |
| AR (1) | AR053948A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006265275A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0612591A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2613187A1 (cg-RX-API-DMAC7.html) |
| CR (1) | CR9635A (cg-RX-API-DMAC7.html) |
| EC (1) | ECSP088081A (cg-RX-API-DMAC7.html) |
| IL (1) | IL188317A0 (cg-RX-API-DMAC7.html) |
| MA (1) | MA29730B1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2008000277A (cg-RX-API-DMAC7.html) |
| MY (1) | MY157955A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20076662L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ564471A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2008103608A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI312864B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007003420A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001264696B2 (en) | 2000-05-19 | 2007-01-04 | Genentech, Inc. | Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy |
| ZA200701234B (en) * | 2004-07-22 | 2008-12-31 | Genentech Inc | HER2 antibody composition |
| US7936392B2 (en) | 2004-10-01 | 2011-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Imaging arrangements and methods therefor |
| WO2007092545A2 (en) | 2006-02-07 | 2007-08-16 | The Board Of Trustees Of The Leland Stanford Junior University | Variable imaging arrangements and methods therefor |
| JO3000B1 (ar) * | 2004-10-20 | 2016-09-05 | Genentech Inc | مركبات أجسام مضادة . |
| CA2596133C (en) | 2005-02-23 | 2016-11-15 | Genentech, Inc. | Extending time to disease progression or survival in cancer patients |
| PE20070207A1 (es) * | 2005-07-22 | 2007-03-09 | Genentech Inc | Tratamiento combinado de los tumores que expresan el her |
| US8358354B2 (en) | 2009-01-26 | 2013-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Correction of optical abberations |
| CA2677108A1 (en) | 2007-03-02 | 2008-09-12 | Genentech, Inc. | Predicting response to a her inhibitor |
| TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至ｈｅｒ２結構域ii之抗體及其酸性變異體的組合物 |
| BRPI0812682A2 (pt) | 2008-06-16 | 2010-06-22 | Genentech Inc | tratamento de cáncer de mama metastático |
| PT4403228T (pt) | 2011-10-14 | 2025-10-07 | Hoffmann La Roche | Utilizações do inibidor da dimerização de her2 pertuzumab e artigo de fabrico que inclui o mesmo |
| KR101327542B1 (ko) * | 2012-03-15 | 2013-11-08 | 광주과학기술원 | 양자점 기반의 경쟁 면역분석법 및 다중 유세포 분석법을 이용한 시료 중 오염물질의 검출 방법 |
| AU2012232949B2 (en) * | 2012-09-28 | 2014-07-03 | Willowtree Holdings Pty Ltd | Temporary bulkhead |
| US9815904B2 (en) | 2013-04-16 | 2017-11-14 | Genetech, Inc. | Pertuzumab variants and evaluation thereof |
| KR20160141857A (ko) | 2014-04-25 | 2016-12-09 | 제넨테크, 인크. | 트라스투주맙-mcc-dm1 및 퍼투주맙을 이용하는 초기 유방암의 치료방법 |
| PT3302551T (pt) | 2015-05-30 | 2024-08-21 | H Hoffnabb La Roche Ag | Métodos de tratamento do cancro da mama metastático positivo para her2 não tratado previamente |
| WO2017087280A1 (en) | 2015-11-16 | 2017-05-26 | Genentech, Inc. | Methods of treating her2-positive cancer |
| US20180221481A1 (en) | 2016-12-28 | 2018-08-09 | Genentech, Inc. | Treatment of advanced her2 expressing cancer |
| LT3570884T (lt) | 2017-01-17 | 2020-12-10 | Genentech, Inc. | Poodinės her2 antikūnų kompozicijos |
| JP6992081B2 (ja) | 2017-03-02 | 2022-02-03 | ジェネンテック， インコーポレイテッド | Ｈｅｒ２陽性乳癌のアジュバント治療 |
| WO2018200505A1 (en) | 2017-04-24 | 2018-11-01 | Genentech, Inc. | Erbb2/her2 mutations in the transmbrane or juxtamembrane domain |
| MX2022015884A (es) | 2020-06-29 | 2023-04-03 | Genentech Inc | Combinacion de dosis fija de pertuzumab mas trastuzumab. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2095818B (en) | 1981-03-27 | 1985-10-02 | Exxon Research Engineering Co | Staged adsorption/resorption heat pump |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| CA2103059C (en) * | 1991-06-14 | 2005-03-22 | Paul J. Carter | Method for making humanized antibodies |
| WO1993021319A1 (en) | 1992-04-08 | 1993-10-28 | Cetus Oncology Corporation | HUMANIZED C-erbB-2 SPECIFIC ANTIBODIES |
| CN101412758A (zh) | 1996-10-18 | 2009-04-22 | 基因技术股份有限公司 | 抗ErbB2抗体 |
| JP4424987B2 (ja) | 2001-09-20 | 2010-03-03 | ボード オブ リージェンツ， ザ ユニバーシティ オブ テキサス システム | Ｅｌｉｓａアッセイを用いた循環する治療抗体、抗原および抗原／抗体複合体の測定 |
| AU2003273218C1 (en) * | 2002-07-15 | 2019-01-17 | F. Hoffmann - La Roche Ag | Methods for identifying tumors that are responsive to treatment with anti-ErbB2 antibodies |
-
2006
- 2006-06-29 US US11/477,772 patent/US20070009976A1/en not_active Abandoned
- 2006-06-29 MY MYPI20063118A patent/MY157955A/en unknown
- 2006-07-04 TW TW095124248A patent/TWI312864B/zh active
- 2006-07-04 AR ARP060102872A patent/AR053948A1/es not_active Application Discontinuation
- 2006-07-05 EP EP10157725A patent/EP2194380A3/en not_active Withdrawn
- 2006-07-05 EP EP06754671A patent/EP1902315A1/en not_active Withdrawn
- 2006-07-05 CA CA002613187A patent/CA2613187A1/en not_active Abandoned
- 2006-07-05 JP JP2008519853A patent/JP2008545145A/ja active Pending
- 2006-07-05 NZ NZ564471A patent/NZ564471A/en unknown
- 2006-07-05 RU RU2008103608/15A patent/RU2008103608A/ru unknown
- 2006-07-05 KR KR1020087000259A patent/KR20080016939A/ko not_active Ceased
- 2006-07-05 WO PCT/EP2006/006524 patent/WO2007003420A1/en not_active Ceased
- 2006-07-05 BR BRPI0612591-3A patent/BRPI0612591A2/pt not_active IP Right Cessation
- 2006-07-05 AU AU2006265275A patent/AU2006265275A1/en not_active Abandoned
- 2006-07-05 MX MX2008000277A patent/MX2008000277A/es not_active Application Discontinuation
-
2007
- 2007-12-20 IL IL188317A patent/IL188317A0/en unknown
- 2007-12-21 CR CR9635A patent/CR9635A/es not_active Application Discontinuation
- 2007-12-28 NO NO20076662A patent/NO20076662L/no not_active Application Discontinuation
-
2008
- 2008-01-04 EC EC2008008081A patent/ECSP088081A/es unknown
- 2008-02-01 MA MA30617A patent/MA29730B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1902315A1 (en) | 2008-03-26 |
| CA2613187A1 (en) | 2007-01-11 |
| AR053948A1 (es) | 2007-05-23 |
| MX2008000277A (es) | 2008-03-24 |
| KR20080016939A (ko) | 2008-02-22 |
| CR9635A (es) | 2008-02-20 |
| MY157955A (en) | 2016-08-30 |
| NZ564471A (en) | 2010-04-30 |
| US20070009976A1 (en) | 2007-01-11 |
| ECSP088081A (es) | 2008-02-20 |
| NO20076662L (no) | 2008-04-03 |
| AU2006265275A1 (en) | 2007-01-11 |
| JP2008545145A (ja) | 2008-12-11 |
| MA29730B1 (fr) | 2008-09-01 |
| EP2194380A3 (en) | 2010-07-14 |
| BRPI0612591A2 (pt) | 2010-11-23 |
| EP2194380A2 (en) | 2010-06-09 |
| TW200741203A (en) | 2007-11-01 |
| WO2007003420A1 (en) | 2007-01-11 |
| IL188317A0 (en) | 2008-04-13 |
| TWI312864B (en) | 2009-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008103608A (ru) | Выявление антигена-мишени вне зависимости от присутствия или отсутствия соответствующего терапевтического антитела | |
| CY1112631T1 (el) | ΜΕΘΟΔΟΙ ΤΑΥΤΟΠΟΙΗΣΗΣ ΟΓΚΩΝ ΠΟΥ ΑΠΟΚΡΙΝΟΝΤΑΙ ΣΕ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ΕrbB2 | |
| JP2008545145A5 (cg-RX-API-DMAC7.html) | ||
| CN110546513A (zh) | 使用早期生物标记物帮助超急性诊断和确定人类受试者中的创伤性脑损伤的方法 | |
| WO2018175942A1 (en) | Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1 | |
| WO2010038974A3 (ko) | 이뮤노글로블린 에이 신증과 티지비엠 신증의 진단용 조성물 및 키트 | |
| FR2933773B1 (fr) | Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal | |
| JP2020517306A5 (cg-RX-API-DMAC7.html) | ||
| Lei et al. | Application of an immunomagnetic bead ELISA based on IgY for detection of circulating antigen in urine of mice infected with Schistosoma japonicum | |
| JP4608432B2 (ja) | 腫瘍マーカーとしてのｎ▲１▼，ｎ▲１２▼−ジアセチルスペルミン | |
| WO2017125892A3 (es) | Anticuerpos monoclonales específicos para el antígeno piii de adenovirus humano (adv), producidos y secretados por hibridomas celulares, útiles para la detección y el diagnóstico de la infección causada por adv | |
| FI3356826T3 (fi) | Gdf-15 melanooman diagnostisena markkerina | |
| US9465030B2 (en) | Kit for diagnosing malignant melanoma | |
| MX2007006895A (es) | Deteccion de un anticuerpo terapeutico en animal de experimentacion. | |
| EP1476757A4 (en) | METHOD AND KIT FOR PREDICTING CANCER | |
| US11242408B2 (en) | Monoclonal antibody specific for gamma-glutamyl-l-epsilon-lysine for the monitoring of apoptosis | |
| ATE532796T1 (de) | Immunassays zur spezifischen bestimmung von scca- isoformen | |
| ATE493662T1 (de) | Diagnostischer test für menschliches matrix gla- protein und seine verwendung als biomarker | |
| EP3602069A1 (en) | Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1 | |
| WO2023034777A1 (en) | Methods and systems of diagnosing brain injury | |
| KR20240139074A (ko) | 샘플에서 유비퀴틴 카르복시-말단 히드롤라제 l1 및/또는 신경교 섬유성 산성 단백질의 존재를 검출하거나 또는 그의 양을 측정하기 위한 측면 유동 방법, 검정 및 기기 | |
| CN108770366A (zh) | β防御素在上皮性癌评估中的应用 | |
| WO2024040238A3 (en) | Method of diagnosing and treating prostate cancer using zinc finger protein-like 1 antibodies | |
| EA202090834A1 (ru) | Набор реагентов для выявления маркера эпителиальных карцином | |
| JP2025503439A (ja) | 血液試料におけるｕｃｈ－ｌ１、ｇｆａｐ及び他のバイオマーカーを決定するためのシステム及び方法 |